Sanara MedTech SMTI
Sanara MedTech FY 2020: revenue $15.6M; diluted EPS −$0.76
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001654954-21-003520
- Document
- 10-K
- Exhibit 4.1
- Description of securities
- Exhibit 10.1
- Form of restricted stock award agreement
Key figures from this report
These are the numbers Sanara MedTech reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$15.6MNo year-earlier figure tagged10-K income statement, on EDGAR
- Net income−$4.4MNo year-earlier figure tagged10-K income statement, on EDGAR
- Diluted EPS−$0.76No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$455KNo year-earlier figure tagged10-K balance sheet, on EDGAR
- Cash from operations−$4.0MNo year-earlier figure tagged10-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3842 and related industry codes: the same peer list as the financial tables.
- Anika Therapeutics ANIK public float $147M, Jun 30, 2025
- Stereotaxis STXS public float $150M, Jun 30, 2025
- Profound Medical PROF public float $152M, Jun 30, 2025
- Sight Sciences SGHT public float $154M, Jun 30, 2025
- AVITA Medical RCEL public float $139M, Jun 30, 2025